My watch list  

GVK Biosciences Joins ResearchPoint Global

Addition of India-based CRO expands reach of worldwide clinical organization


ResearchPoint Global (RPG) announced its newest member, GVK Biosciences (GVK BIO). GVK BIO provides RPG with access to an extensive network of experienced and proven investigative sites and country-specific regulatory, clinical and technical expertise.

As the growth of India’s participation in global clinical programs continues to increase at a rapid pace, RPG strategically sought to expand its reach to this region. According to The Goldman Sachs Group, Inc., “India presents an attractive region for clinical trials given a population of over one billion, a large number of English-speaking patients, and a well developed information technology industry.” 1

RPG’s expansion into India offers numerous advantages for running clinical trials: a large population, qualified medical personnel, and well-established regulations. GVK BIO complements RPG’s current presence in the Americas, Europe (Western, Central, and Eastern) and Africa.

“RPG is strategically expanding our global footprint with qualified, like-minded CROs who have extensive drug development experience across a broad range of therapeutic areas,” said Matt Walker, Executive Vice President of Marketing and Business Development with ResearchPoint, a member of RPG. “GVK Biosciences has built an exceptional reputation as a full-service clinical service provider in India and we look forward to leveraging their deep local knowledge for the benefit of our clients.”

Facts, background information, dossiers
More about GVK Biosciences
More about ResearchPoint Global
  • Companies

    ResearchPoint Global

    ResearchPoint Global (RPG) is a worldwide clinical organization with 22 regional offices and coverage in 65 countries. As a proven global organization, RPG involves truly local resources to navigate regional issues and consists of high-performing teams whose principals are actively engaged ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE